| Tamar S Ginsberg, CCC SLP | |
|
204 W Broad St, Bergenfield, NJ 07621-2804 | |
| (201) 384-1859 | |
| Not Available |
| Full Name | Tamar S Ginsberg |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 204 W Broad St, Bergenfield, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609136522 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 019462 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Tamar S Ginsberg, CCC SLP 204 W Broad St, Bergenfield, NJ 07621-2804 Ph: (201) 384-1859 | Tamar S Ginsberg, CCC SLP 204 W Broad St, Bergenfield, NJ 07621-2804 Ph: (201) 384-1859 |
News Archive
Gluten-free bread, which is suitable for patients with celiac disease, has been supplemented to resemble French bread in terms of texture and color, according to a study in the Journal of Food Science, published by the Institute of Food Technologists (IFT).
A 10-year investigation evaluating data from four surveillance systems captured information on the geographic distribution of outbreaks of Salmonella enterica serotype Newport infections in the U.S., who is at greatest risk, the rate of antimicrobial resistance of Newport infections, and how often antimicrobial resistance may be linked to an environmental cause of infection.
ALS is a fatal neurodegenerative disease causing a rapid loss of motor function, which usually results in a serious condition with early death within a few years.
ChemGenex Pharmaceuticals Limited announced today that the U.S. Food & Drug Administration (FDA) has accepted the company's New Drug Application (NDA) for Omapro™ (omacetaxine mepesuccinate) for the treatment of patients with chronic myeloid leukemia (CML) who have failed treatment with imatinib and who have developed the Bcr-Abl T315I mutation.
LTC Properties, Inc. (NYSE:LTC) announced today that it had declared the quarterly cash dividend of $0.53125 per share on its 8.5% Series E Cumulative Convertible Preferred Stock. The dividend is payable on October 15, 2009 to stockholders of record on October 1, 2009.
› Verified 9 days ago
Luz Torres Bustamante, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 67 Garden St, Bergenfield, NJ 07621 Phone: 551-655-5630 | |
Liat Herskovitz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 59 Deerfield St, Bergenfield, NJ 07621 Phone: 201-385-4052 | |
Keren Nussbaum, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 60 Glenwood Drive S, Bergenfield, NJ 07621 Phone: 973-747-2731 | |
Mrs. Mary Grace Ruiz, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 37 Smith Ave, Bergenfield, NJ 07621 Phone: 201-693-5237 | |
Sima Raphan, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 77 Garden St, Bergenfield, NJ 07621 Phone: 917-613-0835 Fax: 201-338-8254 | |
Mrs. Shira Renee Greenberg, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 35 Hampton Ct, Bergenfield, NJ 07621 Phone: 201-385-9620 | |
The Way You Say Llc Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 101 Hillside Ave, Bergenfield, NJ 07621 Phone: 201-923-7374 |